A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers
Phase of Trial: Phase II
Latest Information Update: 06 Oct 2016
Price : $35 *
At a glance
- Drugs HP 802247 (Primary)
- Indications Varicose ulcer
- Focus Biomarker; Pharmacodynamics
- Acronyms MOA 034
- Sponsors Smith & Nephew
- 28 Jan 2015 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
- 18 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.